Brief: Quantum Genomics FY Operating Loss Widens To 13.9 Million Euros

Quantum Genomics SA

25/03/2021 17:47

March 25 (Reuters) - Quantum Genomics SA  ALQGC.PA :
    * QUANTUM GENOMICS REPORTS FULL YEAR 2020 OPERATING AND
FINANCIAL
RESULTS
    * STRONG CASH POSITION OF EUR 27.1 MILLION AT DECEMBER 2020
    * NET INCOME STOOD AT -EUR 11.5 MILLION AS OF DECEMBER 2020
    * RECRUITMENT OF FIRST SUBJECTS FOR PHASE III TRIAL IN
DIFFICULT-TO-TREAT AND RESISTANT ARTERIAL HYPERTENSION PATIENTS
    * FINALIZATION OF RECRUITMENT FOR PHASE IIB TRIAL IN HEART
FAILURE
WITH UPCOMING RESULTS EXPECTED IN 2021
    * LICENSING AGREEMENT ACTIVITIES ACCELERATION IN SECOND
SEMESTER
2020
    * -EUR 13.9 MILLION FOR 2020 OPERATING INCOME, COMPARED TO
-EUR
10.8 MILLION A YEAR EARLIER
    * PREVIOUS OPERATIONS LED TO A TOTAL REVENUE OF EUR 2.3
MILLION
FOR 2020

Source text for Eikon:  ID:nNDL2G4KZJ 
Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))